Pro-Dex, Inc.

PDEX Healthcare Medical Instruments & Supplies

Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025.

Revenue
+11.0%
EPS
−33.6%
Free cash flow
+177.8%
Total debt
+42.2%

Quarter to September 2026, against a year earlier

61.57 1.87 −2.95%
Market cap
$195.8M
P/E
16.4×
Fwd P/E
18.8×
Dividend yield
—
F-score
6/9
Altman Z
7.38
Beneish M
−1.11
Dividend safety
n/a

Pro-Dex, Inc. (PDEX) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Pro-Dex, Inc. (PDEX) trades at a P/E ratio of 16.4×. Over the past ten years it has ranged from 0.0× (December 2015) to 62.7× (March 2016); the current reading is higher than 60% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 13.8× (12.46%)
FY2025 15.8× (45.71%)
FY2024 29.1× 183.65%
FY2023 10.3× (19.16%)
FY2022 12.7× (36.26%)
FY2021 19.9× 75.35%
FY2020 11.4× (15.33%)
FY2019 13.4× (22.71%)
FY2018 17.4× 255.95%
FY2017 4.9× (82.45%)

Quarterly newest first

Period P/E ratio Change
Sep 2026 18.4× 32.93%
Jun 2026 13.8× 4.26%
Mar 2026 13.3× 19.72%
Dec 2025 11.1× 12.37%
43 more quarters

Against its own ten years

Low 0.0× High 62.7×
Ten-year median 15.0×
Current reading's percentile 56

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PDEX